目的探讨胸腺肽联合果糖二磷酸钠治疗小儿病毒性心肌炎的疗效。方法将60例小儿病毒性心肌炎患者随机分为对照组和治疗组各30例,对照组予以常规治疗,治疗组在常规治疗基础上加用胸腺肽联合果糖二磷酸钠。结果治疗后,治疗组总有效率96.67%,对照组总有效率73.33%,两组比较差异有统计学意义(P<0.05);治疗组心电图改善情况优于对照组(P<0.05);治疗组的CK、CK-MB、LDH较对照组有明显改善(P<0.05)。结论胸腺肽联合果糖二磷酸钠对病毒性心肌炎患儿疗效好,临床症状消失快,降低心肌酶,值得临床推广和应用。 Objective To investigate the efficacy of thymosin combined with sodium fructose diphosphate in the treatment of viral myocarditis in children. Methods Sixty children with viral myocarditis were randomly divided into control group and treatment group, 30 cases in each group. The control group was given conventional treatment. The treatment group was given thymosin combined with sodium fructose diphosphate on the basis of routine treatment. Results After treatment, the total effective rate was 96.67% in the treatment group and 73.33% in the control group, with significant difference between the two groups (P <0.05). The improvement of electrocardiogram in the treatment group was better than that in the control group (P <0.05) CK, CK-MB, LDH of the group were significantly improved compared with the control group (P <0.05). Conclusion Thymosin combined with sodium fructose diphosphate in children with viral myocarditis effective, rapid disappearance of clinical symptoms, reduce myocardial enzymes, deserved clinical promotion and application.